Avecho Biotechnology (AVE.AX) Earnings Analysis
Avecho Biotechnology (AVE.AX) has no confirmed upcoming earnings date. Trailing P/E -15.71.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AVE.AX next report earnings?
No confirmed upcoming earnings date is currently scheduled for AVE.AX. This page updates as the calendar is published.
AVE.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-28 | -0.001 AUD | n/a | n/a | n/a |
| 2025-08-25 | -0.00042 AUD | n/a | n/a | n/a |
| 2025-03-06 | -0.0003 AUD | n/a | n/a | n/a |
AVE.AX valuation and analyst view
| Trailing P/E | -15.71 |
|---|---|
| Trailing EPS | -0.0009 AUD |
| Price / book | 48.32 |
| Dividend yield | 0.00% |
| Market cap | 0.07B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Avecho Biotechnology (AVE.AX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AVE.AX. This page updates as the calendar is published.
Did AVE.AX beat earnings last quarter?
Consensus estimate data was not available for AVE.AX's 2026-01-28 report.
What is AVE.AX's current P/E ratio and EPS?
AVE.AX trades at a trailing P/E of -15.71 on trailing EPS of -0.0008986854763239696 AUD.
What do analysts rate AVE.AX?
AVE.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.